Inc
-
Cipla enters into a licensing agreement with MSD
To expand access to investigational oral therapeutic drug for COVID-19 treatment Cipla has signed a non-exclusive licensing agreement with MSD…
Read More »
To expand access to investigational oral therapeutic drug for COVID-19 treatment Cipla has signed a non-exclusive licensing agreement with MSD…
Read More »